Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | 121.26K | 0.00%10K | 10K | |||||||
| Other cash income from operating activities | --121.26K | ---- | ---- | ---- | 0.00%10K | --10K | ---- | ---- | ---- | ---- |
| Cash paid | 53.25%-297.67K | 1.28%-636.76K | 44.41%-645.04K | -133.20%-1.16M | -60.41%-497.55K | -11.96%-310.18K | 54.87%-277.04K | -22.94%-613.92K | 32.96%-499.39K | 57.69%-744.92K |
| Payments to suppliers for goods and services | 53.25%-297.67K | 1.28%-636.76K | 44.41%-645.04K | -133.20%-1.16M | -60.41%-497.55K | -11.96%-310.18K | 54.87%-277.04K | -22.94%-613.92K | 32.96%-499.39K | 57.69%-744.92K |
| Direct interest received | -83.55%4.69K | -59.48%28.5K | 965.65%70.33K | -52.01%6.6K | -52.89%13.75K | -52.20%29.19K | -0.86%61.07K | 77.57%61.6K | 12.98%34.69K | 260.42%30.71K |
| Operating cash flow | 71.77%-171.72K | -5.84%-608.26K | 50.19%-574.71K | -143.50%-1.15M | -74.84%-473.8K | -25.48%-270.99K | 60.90%-215.97K | -18.86%-552.32K | 34.94%-464.69K | -237.35%-714.21K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 58.85%-505.96K | -15.24%-1.23M | 36.89%-1.07M | -280.56%-1.69M | -692.72%-444.19K | 79.90%-56.03K | -1,319.54%-278.73K | -19.64K | -99.39%5.61K | |
| Capital expenditure reported | 58.85%-505.96K | -15.24%-1.23M | 36.89%-1.07M | -280.56%-1.69M | -692.72%-444.19K | 79.90%-56.03K | -1,319.54%-278.73K | ---19.64K | ---- | 100.68%5.61K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 58.85%-505.96K | -15.24%-1.23M | 36.89%-1.07M | -280.56%-1.69M | -692.72%-444.19K | 79.90%-56.03K | -1,319.54%-278.73K | ---19.64K | ---- | -99.39%5.61K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -0.77%445.05K | -13.31%448.48K | -56.70%517.36K | -51.87%1.19M | 2.48M | -91.18%80.08K | 907.38K | |||
| Net issuance payments of debt | --445K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net common stock issuance | -99.99%50 | -13.31%448.48K | -56.70%517.36K | -51.87%1.19M | --2.48M | ---- | -91.18%80.08K | --907.38K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -0.77%445.05K | -13.31%448.48K | -56.70%517.36K | -51.87%1.19M | --2.48M | ---- | -91.18%80.08K | --907.38K | ---- | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | -61.25%879.64K | -33.12%2.27M | -32.70%3.39M | 44.97%5.04M | -8.59%3.48M | -9.82%3.81M | 8.63%4.22M | -10.68%3.89M | -10.47%4.35M | 75.48%4.86M |
| Current changes in cash | 83.25%-232.63K | -23.58%-1.39M | 31.84%-1.12M | -205.42%-1.65M | 578.38%1.56M | 21.13%-327.02K | -223.61%-414.62K | 172.18%335.43K | 34.42%-464.69K | -149.34%-708.6K |
| Effect of exchange rate changes | ---- | ---976 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -69.39%200.08K |
| End cash Position | -26.45%647.01K | -61.25%879.64K | -33.12%2.27M | -32.70%3.39M | 44.97%5.04M | -8.59%3.48M | -9.82%3.81M | 8.63%4.22M | -10.68%3.89M | -10.47%4.35M |
| Free cash from | 63.12%-677.68K | -11.95%-1.84M | 42.28%-1.64M | -209.82%-2.84M | -180.71%-917.98K | 33.89%-327.02K | 13.51%-494.69K | -23.08%-571.95K | 34.94%-464.69K | -22.97%-714.21K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |